Izotropic Corporation
IZOZF
$0.26
$0.01757.22%
| Weiss Ratings | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.21 | |||
| Price History | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 13.04% | |||
| 30-Day Total Return | 82.46% | |||
| 60-Day Total Return | 614.29% | |||
| 90-Day Total Return | 510.33% | |||
| Year to Date Total Return | 398.08% | |||
| 1-Year Total Return | 160.00% | |||
| 2-Year Total Return | -21.04% | |||
| 3-Year Total Return | -45.53% | |||
| 5-Year Total Return | 147.62% | |||
| 52-Week High % Change | -18.75% | |||
| 52-Week Low % Change | 1,297.85% | |||
| Price | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.32 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Dec 11, 2024 | |||
| 52-Week High Price (Date) | Jan 22, 2025 | |||
| Valuation | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 15.30M | |||
| Enterprise Value | 16.63M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.03 | |||
| Earnings Per Share Growth | -61.18% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -4.55 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.26 | |||
| Enterprise Value/EBITDA (TTM) | -11.84 | |||
| Enterprise Value/EBIT | -11.73 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 56.80M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (833) 496-2677 | |||
| Address | 800-15355 24th Avenue Surrey, BC V4A 2H9 | |||
| Website | izocorp.com | |||
| Country | Canada | |||
| Year Founded | 2016 | |||
| Profitability | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -381.67% | |||
| Return on Equity | -- | |||
| Income Statement | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -1.40M | |||
| EBIT (TTM) | -1.42M | |||
| Net Income (TTM) | -1.39M | |||
| Net Income Avl. to Common (TTM) | -1.39M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 56.67% | |||
| EPS Diluted (TTM) | -0.03 | |||
| EPS Diluted Growth (Q YOY) | 59.09% | |||
| Balance Sheet | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 83.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 168.10K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -3.24M | |||
| Current Ratio (Q) | 0.049 | |||
| Book Value Per Share (Q) | -$0.06 | |||
| Total Assets (Q) | 197.00K | |||
| Total Current Liabilities (Q) | 3.44M | |||
| Total Debt (Q) | 1.46M | |||
| Total Liabilities (Q) | 3.44M | |||
| Total Common Equity (Q) | -3.24M | |||
| Cash Flow | IZOZF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 174.60K | |||
| Net Change in Cash (TTM) | -32.30K | |||
| Levered Free Cash Flow (TTM) | -294.50K | |||
| Cash from Operations (TTM) | -209.80K | |||
